e-learning
resources
Virtual 2020
Pre-Congress Content
Advances in asthma treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inter-rater reliability of a novel algorithm to calculate Global Initiative for Asthma (GINA) treatment steps
K. Andreasson (Naestved, Denmark), T. Andreasson (Naestved, Denmark), C. Ulrik (Hvidovre, Denmark), K. Sidenius (Elsinore, Denmark), S. Skou (Slagelse, Denmark), M. Thomas (Southampton , United Kingdom), U. Bodtger (Naestved, Denmark)
Source:
Virtual Congress 2020 – Advances in asthma treatment
Session:
Advances in asthma treatment
Session type:
E-poster session
Number:
2614
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Andreasson (Naestved, Denmark), T. Andreasson (Naestved, Denmark), C. Ulrik (Hvidovre, Denmark), K. Sidenius (Elsinore, Denmark), S. Skou (Slagelse, Denmark), M. Thomas (Southampton , United Kingdom), U. Bodtger (Naestved, Denmark). Inter-rater reliability of a novel algorithm to calculate Global Initiative for Asthma (GINA) treatment steps. 2614
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care
Source: Eur Respir J 2012; 39: 1220-1229
Year: 2012
Concordance between Asthma Control Test and the revised GINA criteria of asthma control
Source: International Congress 2017 – Monitoring asthma control
Year: 2017
Comparing Global Initiative for Asthma (GINA) criteria with the Childhood Asthma Control Test (C-ACT) and Asthma Control Test (ACT)
Source: Eur Respir J 2011; 38: 561-566
Year: 2011
The Global Initiative for Asthma (GINA): 25 years later
Source: Eur Respir J, 54 (2) 1900598; 10.1183/13993003.00598-2019
Year: 2019
Asthma Control Test (ACT) or Asthma Control Questionnaire (ACQ)? - validity and responsiveness in children.
Source: International Congress 2017 – Diagnostic tools in paediatric asthma
Year: 2017
Categorization of asthma patients by Global Initiative for Asthma (GINA) 2018 guidelines using a US administrative claims database
Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes
Year: 2020
Rasch validation of the Asthma Control Questionnaire
Source: International Congress 2019 – Exercise and physiotherapy in patients with asthma, cystic fibrosis, bronchiectasis and primary ciliary dyskinesia
Year: 2019
Use of Asthma Control Questionnaire (ACQ) Score to predict future risk of asthma exacerbation
Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma
Year: 2010
The cut-off values for Visual Analogue Scale (VAS) and for the Assessment Tool for Asthma (ATA) according the Control for Asthma and Allergic Rhinitis Test (CARAT)
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021
Association of Asthma Control Test (ACT) and Asthma Control Questionnaire (ACQ) with asthma exacerbation
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Year: 2018
The validation of the Severe Asthma Questionnaire (SAQ).
Source: International Congress 2018 – Asthma management
Year: 2018
Development and validation of the RAND Asthma Control Measure
Source: Eur Respir J 2014; 44: 1243-1252
Year: 2014
Validity of the Asthma Control Questionnaire to detect uncontrolled asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 249s
Year: 2005
Asthma Control Test (ACT) scores and FE
NO
correlation
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007
Reliability and validity of TAPQOL questionnaire for the assessment of global health related quality of life (HRQL) in children with Paediatric Central Airway Obstructive Disease (PCAOD)
Source: International Congress 2017 – Paediatric bronchology in clinical practice
Year: 2017
Reliability and validity of the Asthma Control TestÔ (ACT) paper and telephone formats
Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care
Year: 2008
Global Lung Function Initiative 2012 reference equations for spirometry in the Norwegian population
Source: Eur Respir J 2016; 48: 1602-1611
Year: 2016
Asthma Control Questionnaire in children: validation, measurement properties, interpretation
Source: Eur Respir J 2010; 36: 1410-1416
Year: 2010
Validity and reliability of the Stanford Brief Activity Survey (SBAS) in patients with COPD
Source: Annual Congress 2010 - Outcomes in chronic lung disease: assessing the value of interventions – physical activity, strength and exercise
Year: 2010
Linguistic validation of the Clinical COPD Questionnaire (CCQ) for use in international studies
Source: Eur Respir J 2005; 26: Suppl. 49, 513s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept